(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $699.18 | $360.79 | $382.92 | $428.96 |
Short term investments | $1156.81 | $454.8 | $529.16 | $482.58 |
Net receivables | $1.25 | $0.31 | $2.51 | $4 |
Inventory | ||||
Total current assets | $1879.28 | $824.47 | $922.09 | $922.75 |
Long term investments | ||||
Property, plant & equipment | $100.01 | $73.41 | $73.45 | $72.84 |
Goodwill & intangible assets | $72.35 | $72.61 | $72.88 | $73.15 |
Total noncurrent assets | $182.42 | $159.76 | $151.62 | $150.5 |
Total investments | $1156.81 | $454.8 | $529.16 | $482.58 |
Total assets | $2061.7 | $984.23 | $1073.71 | $1073.25 |
Current liabilities | ||||
Accounts payable | $61.79 | $29.63 | $29.78 | $19.91 |
Deferred revenue | $1.43 | |||
Short long term debt | $7.37 | $5.75 | $5.72 | $5.92 |
Total current liabilities | $143.85 | $85.54 | $78.06 | $54.63 |
Long term debt | $80.58 | $57.09 | $57.54 | $57.68 |
Total noncurrent liabilities | $91.66 | $61.23 | $64.81 | $66.39 |
Total debt | $87.94 | $62.85 | $63.26 | $63.6 |
Total liabilities | $235.51 | $146.77 | $142.87 | $121.03 |
Shareholders' equity | ||||
Retained earnings | -$1137.71 | -$976.17 | -$867.74 | -$769.44 |
Other shareholder equity | $0.54 | -$0.87 | -$1.25 | -$0.56 |
Total shareholder equity | $1826.19 | $837.46 | $930.84 | $952.22 |
(in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $699.18 | $163.15 | $110.23 | $105.35 |
Short term investments | $1156.81 | $483.53 | $468.56 | $336.47 |
Net receivables | $1.25 | $4.67 | $5.93 | $6.39 |
Inventory | ||||
Total current assets | $1879.28 | $660.18 | $589.77 | $454.12 |
Long term investments | ||||
Property, plant & equipment | $100.01 | $73.74 | $71.24 | $36.34 |
Goodwill & intangible assets | $72.35 | $73.42 | $74.48 | $75.55 |
Total noncurrent assets | $182.42 | $151.75 | $148.22 | $113.28 |
Total investments | $1156.81 | $483.53 | $468.56 | $336.47 |
Total assets | $2061.7 | $811.93 | $737.99 | $567.4 |
Current liabilities | ||||
Accounts payable | $61.79 | $21.31 | $14.06 | $12.61 |
Deferred revenue | $4.46 | $18.93 | $20.59 | |
Short long term debt | $7.37 | $6.77 | $6.21 | $3.67 |
Total current liabilities | $143.85 | $61.98 | $60.35 | $47.18 |
Long term debt | $80.58 | $57.43 | $60.42 | $28.99 |
Total noncurrent liabilities | $91.66 | $64.76 | $75.07 | $45.55 |
Total debt | $87.94 | $64.2 | $66.63 | $32.66 |
Total liabilities | $235.51 | $126.74 | $135.42 | $92.72 |
Shareholders' equity | ||||
Retained earnings | -$1137.71 | -$701.34 | -$452.64 | -$265.55 |
Other shareholder equity | $0.54 | -$1.78 | -$0.38 | $0.12 |
Total shareholder equity | $1826.19 | $685.19 | $602.57 | $474.68 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $0.74 | $3.82 | $7.01 | |
Cost of revenue | ||||
Gross Profit | $0.74 | $3.82 | $7.01 | |
Operating activities | ||||
Research & development | $148.48 | $107.73 | $97.98 | $68.95 |
Selling, general & administrative | $32.24 | $15.51 | $14.64 | $13.22 |
Total operating expenses | $180.72 | $123.25 | $112.62 | $82.17 |
Operating income | -$179.98 | -$123.25 | -$108.8 | -$75.16 |
Income from continuing operations | ||||
EBIT | -$160.89 | -$112.3 | -$98.3 | -$68.1 |
Income tax expense | $0.34 | -$3.87 | ||
Interest expense | $0.3 | |||
Net income | ||||
Net income | -$161.54 | -$108.43 | -$98.3 | -$68.1 |
Income (for common shares) | -$161.54 | -$108.43 | -$98.3 | -$68.1 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $11.58 | $35.38 | $29.39 | $42.98 |
Cost of revenue | ||||
Gross Profit | $11.58 | $35.38 | $29.39 | $42.98 |
Operating activities | ||||
Research & development | $423.14 | $253.07 | $186.95 | $132.25 |
Selling, general & administrative | $75.62 | $40.59 | $30.45 | $21.43 |
Total operating expenses | $498.76 | $293.66 | $217.4 | $153.68 |
Operating income | -$487.19 | -$258.28 | -$188.01 | -$110.7 |
Income from continuing operations | ||||
EBIT | -$439.59 | -$249.13 | -$187.08 | -$108.46 |
Income tax expense | -$3.52 | -$0.42 | -$0.37 | |
Interest expense | $0.3 | $0.01 | $0.07 | |
Net income | ||||
Net income | -$436.37 | -$248.71 | -$187.09 | -$108.16 |
Income (for common shares) | -$436.37 | -$248.71 | -$187.09 | -$110.38 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | -$161.54 | -$108.43 | -$98.3 | -$68.1 |
Operating activities | ||||
Depreciation | $2.86 | $2.15 | $1.77 | $2.53 |
Business acquisitions & disposals | ||||
Stock-based compensation | $25.43 | $13.67 | $12.98 | $9.7 |
Total cash flows from operations | -$120.56 | -$100.5 | -$67.12 | -$62.39 |
Investing activities | ||||
Capital expenditures | -$2.32 | -$2.54 | -$1.12 | -$1.76 |
Investments | -$378.08 | $79.89 | -$42.42 | $5.75 |
Total cash flows from investing | -$380.4 | $77.35 | -$43.54 | $4 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $2.55 | $1.01 | $64.63 | $324.2 |
Net borrowings | ||||
Total cash flows from financing | $839.35 | $1.01 | $64.63 | $324.2 |
Effect of exchange rate | ||||
Change in cash and equivalents | $338.39 | -$22.13 | -$46.03 | $265.81 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | -$436.37 | -$248.71 | -$187.09 | -$108.16 |
Operating activities | ||||
Depreciation | $9.31 | $9.66 | $7.33 | $6.54 |
Business acquisitions & disposals | ||||
Stock-based compensation | $61.77 | $31.2 | $20.72 | $8.89 |
Total cash flows from operations | -$350.57 | -$224.4 | -$147.18 | -$100.06 |
Investing activities | ||||
Capital expenditures | -$7.73 | -$10.82 | -$6.53 | -$2.93 |
Investments | -$334.87 | -$13.3 | -$135.59 | -$231.3 |
Total cash flows from investing | -$342.6 | -$24.12 | -$142.12 | -$234.23 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $392.39 | $301.39 | $294.6 | $422.78 |
Net borrowings | ||||
Total cash flows from financing | $1229.2 | $301.43 | $294.18 | $422.78 |
Effect of exchange rate | ||||
Change in cash and equivalents | $536.03 | $52.91 | $4.88 | $88.48 |
Analyst unveils new Super Micro Computer stock price target
TheStreet via Yahoo Finance
26 Mar 2024
|
NOVA: A.I. Revolution
KPBS San Diego
21 Mar 2024
|
The Superpowers Of Leaders With ADHD
Forbes
21 Mar 2024
|
Key Acquisitions and AI Are Turning This Veteran Back Into a Competitor
InvestorPlace
21 Mar 2024
|
Ozempic and the Oprah Effect: From Hollywood Vanity Diet to Mainstream Miracle Shot That’s Leading...
WWD
21 Mar 2024
|
Oprah Winfrey tears up recounting her weight loss journey in primetime special - East Idaho News
EastIdahoNews.com
20 Mar 2024
|
Revolution Medicines CEO sells over $182k in company stock By Investing.com
Investing.com
20 Mar 2024
|
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance
28 Feb 2024
|
Earnings call: Revolution Medicine reports progress in RAS inhibitor pipeline By Investing.com
Investing.com
28 Feb 2024
|
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance
26 Feb 2024
|
Market cap | $5.31B |
---|---|
Enterprise value | $4.70B |
Shares outstanding | 164.67M |
Revenue | $11.58M |
---|---|
EBITDA | -$430.28M |
EBIT | -$439.59M |
Net Income | -$436.37M |
Revenue Q/Q | -95.16% |
Revenue Y/Y | N/A |
P/E ratio | -12.16 |
---|---|
EV/Sales | 405.55 |
EV/EBITDA | -10.91 |
EV/EBIT | -10.68 |
P/S ratio | 458.33 |
P/B ratio | 2.91 |
Book/Share | 11.09 |
Cash/Share | 4.25 |
EPS | -$2.65 |
---|---|
ROA | -33.61% |
ROE | -38.39% |
Debt/Equity | 0.13 |
---|---|
Net debt/EBITDA | 1.08 |
Current ratio | 13.06 |
Quick ratio | 13.06 |